AI/ML-Enabled Drug Discovery – Part 1

Paid

Cambridge Healthtech Institute’s two-part conference on Artificial Intelligence (AI)/Machine Learning (ML)-Enabled Drug Discovery will highlight the increasing use of computational tools, AI modeling, algorithms, and data science for identifying novel drug targets, drug design, virtual screening, lead optimization, and ADME/toxicology assessments.

26-27 September 2023

Healthcare

Fibrosis and Inflammation

Paid

Fibrosis can be viewed as the end-stage of chronic inflammation. Fibrosis and inflammation are related to the immune system gone awry and both underlie many conditions related to aging and therefore are increasing in prevalence in the US. Cambridge Healthtech Institute's Fibrosis and Inflammation conference continues its fifth year of focusing in t

27-28 September 2023

Healthcare